Skip to main content
An official website of the United States government

axitinib

View Patient Information
An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Inlyta
Code name:AG-013736
AG013736
Chemical structure:N-methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search